HLB Pharmaceutical (Korea) Market Value
| 047920 Stock | KRW 22,500 400.00 1.75% |
| Symbol | HLB |
HLB Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to HLB Pharmaceutical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of HLB Pharmaceutical.
| 06/08/2023 |
| 11/29/2024 |
If you would invest 0.00 in HLB Pharmaceutical on June 8, 2023 and sell it all today you would earn a total of 0.00 from holding HLB Pharmaceutical Co or generate 0.0% return on investment in HLB Pharmaceutical over 540 days. HLB Pharmaceutical is related to or competes with Kolon Life, JETEMA, Aminologics CoLtd, Daihan Pharmaceutical, Withuspharmaceutical, and AnterogenCoLtd. HLB Pharmaceutical Co., Ltd, a pharmaceutical company, develops peptide drugs in South Korea More
HLB Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure HLB Pharmaceutical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess HLB Pharmaceutical Co upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 33.52 | |||
| Value At Risk | (4.34) | |||
| Potential Upside | 6.03 |
HLB Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for HLB Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as HLB Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use HLB Pharmaceutical historical prices to predict the future HLB Pharmaceutical's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.86) | |||
| Treynor Ratio | 0.8049 |
HLB Pharmaceutical Backtested Returns
HLB Pharmaceutical retains Efficiency (Sharpe Ratio) of -0.0477, which attests that the entity had a -0.0477% return per unit of return volatility over the last 3 months. HLB Pharmaceutical exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out HLB Pharmaceutical's Standard Deviation of 4.77, coefficient of variation of (3,775), and Market Risk Adjusted Performance of 0.8149 to validate the risk estimate we provide. The company owns a Beta (Systematic Risk) of -0.17, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning HLB Pharmaceutical are expected to decrease at a much lower rate. During the bear market, HLB Pharmaceutical is likely to outperform the market. At this point, HLB Pharmaceutical has a negative expected return of -0.24%. Please make sure to check out HLB Pharmaceutical's coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if HLB Pharmaceutical performance from the past will be repeated in the future.
Auto-correlation | -0.4 |
Poor reverse predictability
HLB Pharmaceutical Co has poor reverse predictability. Overlapping area represents the amount of predictability between HLB Pharmaceutical time series from 8th of June 2023 to 4th of March 2024 and 4th of March 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of HLB Pharmaceutical price movement. The serial correlation of -0.4 indicates that just about 40.0% of current HLB Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.4 | |
| Spearman Rank Test | -0.32 | |
| Residual Average | 0.0 | |
| Price Variance | 30.4 M |
HLB Pharmaceutical lagged returns against current returns
Autocorrelation, which is HLB Pharmaceutical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting HLB Pharmaceutical's stock expected returns. We can calculate the autocorrelation of HLB Pharmaceutical returns to help us make a trade decision. For example, suppose you find that HLB Pharmaceutical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
HLB Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If HLB Pharmaceutical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if HLB Pharmaceutical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in HLB Pharmaceutical stock over time.
Current vs Lagged Prices |
| Timeline |
HLB Pharmaceutical Lagged Returns
When evaluating HLB Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of HLB Pharmaceutical stock have on its future price. HLB Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, HLB Pharmaceutical autocorrelation shows the relationship between HLB Pharmaceutical stock current value and its past values and can show if there is a momentum factor associated with investing in HLB Pharmaceutical Co.
Regressed Prices |
| Timeline |
Pair Trading with HLB Pharmaceutical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if HLB Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HLB Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.Moving together with HLB Stock
Moving against HLB Stock
The ability to find closely correlated positions to HLB Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace HLB Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back HLB Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling HLB Pharmaceutical Co to buy it.
The correlation of HLB Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as HLB Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if HLB Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for HLB Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in HLB Stock
HLB Pharmaceutical financial ratios help investors to determine whether HLB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HLB with respect to the benefits of owning HLB Pharmaceutical security.